Dr. Ehab L. Atallah
Claim this profileFroedtert Hospital & the Medical College of Wisconsin
Studies Chronic Myeloid Leukemia
Studies Chronic Illness
14 reported clinical trials
38 drugs studied
Area of expertise
1Chronic Myeloid Leukemia
b3a2 (e14a2) positive
b2a2 (e13a2) positive
BCR-ABL1 positive
2Chronic Illness
b3a2 (e14a2) positive
b2a2 (e13a2) positive
BCR-ABL1 positive
Affiliated Hospitals
Clinical Trials Ehab L. Atallah is currently running
Blinatumomab + Chemotherapy
for Leukemia
This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab. Blinatumomab is a Bi-specific T-Cell Engager ('BiTE') that may interfere with the ability of cancer cells to grow and spread. The information gained from this study may help researchers determine if combination therapy with steroids, TKIs, and blinatumomab work better than the standard of care.
Recruiting2 awards Phase 310 criteria
Asciminib Combinations
for Chronic Myeloid Leukemia
This trial tests the effectiveness and safety of a medication called asciminib in patients newly diagnosed with Chronic Myeloid Leukemia in the Chronic Phase. Patients will take asciminib daily, and if they do not respond after a few years, they may also take another low-dose medication. Asciminib works by blocking a protein that helps cancer cells grow.
Recruiting1 award Phase 2
More about Ehab L. Atallah
Clinical Trial Related4 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Ehab L. Atallah has experience with
- Asciminib
- Venetoclax
- Dasatinib
- Imatinib
- Nilotinib
- Azacitidine
Breakdown of trials Ehab L. Atallah has run
Chronic Myeloid Leukemia
Chronic Illness
Acute Myelogenous Leukemia
Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ehab L. Atallah specialize in?
Ehab L. Atallah focuses on Chronic Myeloid Leukemia and Chronic Illness. In particular, much of their work with Chronic Myeloid Leukemia has involved b3a2 (e14a2) positive patients, or patients who are b2a2 (e13a2) positive.
Is Ehab L. Atallah currently recruiting for clinical trials?
Yes, Ehab L. Atallah is currently recruiting for 4 clinical trials in Milwaukee Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Ehab L. Atallah has studied deeply?
Yes, Ehab L. Atallah has studied treatments such as Asciminib, Venetoclax, Dasatinib.
What is the best way to schedule an appointment with Ehab L. Atallah?
Apply for one of the trials that Ehab L. Atallah is conducting.
What is the office address of Ehab L. Atallah?
The office of Ehab L. Atallah is located at: Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wisconsin 53226 United States. This is the address for their practice at the Froedtert Hospital & the Medical College of Wisconsin.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.